Tangansu Zhang

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Gut Microbiota-Immune Interactions in Endometrial Cancer: Causal Mediation and Subtype-Specific Mechanisms.

Gut Microbiota-Immune Interactions in Endometrial Cancer: Causal Mediation and Subtype-Specific Mechanisms.

Journal: International journal of women's health
Published: November 21, 2025

Systematic analyses uncover endocrine-disrupting chemical-responsive genes linked to endometriosis.

Systematic analyses uncover endocrine-disrupting chemical-responsive genes linked to endometriosis.

Journal: Reproductive toxicology (Elmsford, N.Y.)
Published: October 22, 2025

Inhibition of PRMT5 triggers synthetic lethality in ARID1A-deficient endometrial cancer by promoting aberrant R-loop accumulation.

Inhibition of PRMT5 triggers synthetic lethality in ARID1A-deficient endometrial cancer by promoting aberrant R-loop accumulation.

Journal: Molecular cancer
Published: September 24, 2025

Unleashing T cell surveillance for the eradication of quiescent persister tumor cells resistant to neoadjuvant chemotherapy.

Unleashing T cell surveillance for the eradication of quiescent persister tumor cells resistant to neoadjuvant chemotherapy.

Journal: Developmental cell
Published: May 30, 2025

IL-6/KIAA1429 promotes ferroptosis resistance in endometrial cancer through m6A modification of DDIT3.

IL-6/KIAA1429 promotes ferroptosis resistance in endometrial cancer through m6A modification of DDIT3.

Journal: Cellular signalling
Published: November 08, 2024

Dual-Multivalent Aptamer-Based Drug Delivery Platform for Targeted SRC Silencing to Enhance Doxorubicin Sensitivity in Endometrial Cancer.

Dual-Multivalent Aptamer-Based Drug Delivery Platform for Targeted SRC Silencing to Enhance Doxorubicin Sensitivity in Endometrial Cancer.

Journal: International journal of biological sciences
Published: July 17, 2024

Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy.

Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy.

Journal: Cancer cell
Published: May 02, 2024

Ultrasound-responsive Bi2MoO6-MXene heterojunction as ferroptosis inducers for stimulating immunogenic cell death against ovarian cancer.

Ultrasound-responsive Bi2MoO6-MXene heterojunction as ferroptosis inducers for stimulating immunogenic cell death against ovarian cancer.

Journal: Journal of nanobiotechnology
Published: February 28, 2024

lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer.

lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer.

Journal: Molecular carcinogenesis
Published: August 26, 2023

Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer.

Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer.

Journal: BMC cancer
Published: January 18, 2023

KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation.

KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation.

Journal: Molecular carcinogenesis
Published: July 20, 2022

GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1.

GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1.

Journal: BMC cancer
Published: April 12, 2022
Showing 1-12 of 12

Last Updated: 09/26/2026